These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22674103)

  • 1. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
    Alam MA; Sami S; Babu S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.
    Wang XY; Chen Y; Du Q
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiogenesis inhibitors for treatment of angiodysplasia-related gastrointestinal bleeding].
    Bauditz J
    Dtsch Med Wochenschr; 2009 Sep; 134(38):1893-6. PubMed ID: 19746332
    [No Abstract]   [Full Text] [Related]  

  • 4. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
    Bowcock SJ; Patrick HE
    Br J Haematol; 2009 Jul; 146(2):220-2. PubMed ID: 19438503
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias.
    Dabak V; Kuriakose P; Kamboj G; Shurafa M
    Dig Dis Sci; 2008 Jun; 53(6):1632-5. PubMed ID: 17990111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.
    Bauditz J; Lochs H
    World J Gastroenterol; 2007 Dec; 13(45):5979-84. PubMed ID: 18023086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management.
    Becq A; Rahmi G; Perrod G; Cellier C
    Gastrointest Endosc; 2017 Nov; 86(5):792-806. PubMed ID: 28554655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thalidomide therapy for gastrointestinal angiodysplasia].
    Bélard E; Foss CH; Christensen LA; Schmidt P; Nøjgaard C
    Ugeskr Laeger; 2009 Nov; 171(47):3454-5. PubMed ID: 19925735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with thalidomide for a patient with recurrent gastrointestinal bleeding due to angiodysplasia diagnosed by capsule endoscopy.
    Tan HH; Ge ZZ; Chen HM; Gao YJ
    J Dig Dis; 2013 Mar; 14(3):153-5. PubMed ID: 23134426
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide in angiodysplasia-related bleeding.
    Boey JP; Hahn U; Sagheer S; McRae SJ
    Intern Med J; 2015 Sep; 45(9):972-6. PubMed ID: 26332623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric angiodysplasia in a hereditary hemorrhagic telangiectasia type 2 patient.
    Ha M; Kim YJ; Kwon KA; Hahm KB; Kim MJ; Kim DK; Lee YJ; Oh SP
    World J Gastroenterol; 2012 Apr; 18(15):1840-4. PubMed ID: 22553411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias].
    de Koning DB; Drenth JP; Friederich P; Nagengast FM
    Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1994-7. PubMed ID: 17002190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.
    Bauditz J
    World J Gastroenterol; 2016 Mar; 22(11):3158-64. PubMed ID: 27003992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation?
    Muller YD; Oppliger R; Breguet R; Meyer P; Rubbia-Brandt L; Petignat PA; Harr T; Dayer E; Seebach JD
    Liver Int; 2016 Dec; 36(12):1735-1740. PubMed ID: 27864873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
    Invernizzi R; Quaglia F; Klersy C; Pagella F; Ornati F; Chu F; Matti E; Spinozzi G; Plumitallo S; Grignani P; Olivieri C; Bastia R; Bellistri F; Danesino C; Benazzo M; Balduini CL
    Lancet Haematol; 2015 Nov; 2(11):e465-73. PubMed ID: 26686256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: report of one case].
    Vega J; Goecke H; Rodríguez Mde L; Vergara MT
    Rev Med Chil; 2011 Jul; 139(7):909-13. PubMed ID: 22051829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid may be a useful pharmacotherapy for endoscopically resistant small bowel angiodysplasia.
    Fujimori S
    World J Gastroenterol; 2023 Feb; 29(7):1131-1138. PubMed ID: 36926669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide for the treatment of bleeding angiodysplasias.
    Shurafa M; Kamboj G
    Am J Gastroenterol; 2003 Jan; 98(1):221-2. PubMed ID: 12526972
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias.
    Garrido A; Sayago M; López J; León R; Bellido F; Márquez JL
    Rev Esp Enferm Dig; 2012 Feb; 104(2):69-71. PubMed ID: 22372800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.